NMPA Approval

Bemiparin Sodium Injection

Approval Number

国药准字HJ20140018

Registration Date

November 26, 2024

Previous Approval Numbers

H20140018

Drug Information

Generic Name

贝米肝素钠注射液

Trade Name

稀保

Dosage Form

注射剂

Strength

0.2ml:2500IU(抗Xa)

Drug Type

化学药品

Registration Date

November 26, 2024

Expiry Date

November 25, 2029

Company Address

Julián Camarillo, 35 28037 Madrid, Spain

Company Name

rovi pharma industrial services, s.a.

Company Address

Julián Camarillo, 35 28037 Madrid, Spain

Empowering clinical research with data-driven insights and AI-powered tools.

贝米肝素钠注射液 - NMPA 批准文号 | MedPath